Article info

Download PDFPDF

Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis

Authors

  1. Correspondence to Dr Michael Dreyer; michael.dreyer{at}ths.tas.gov.au
View Full Text

Citation

Gounder K, Batt T, Dreyer M
Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis

Publication history

  • Accepted December 1, 2020
  • First published January 18, 2021.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.